Non-Gene Edited Therapeutics: Q&A with Jeffrey Erickson, Vice President of Business Development at Triumvira

Erickson discusses his work developing unique, targeted autologous and allogeneic T cell therapeutics.

Source link
#NonGene #Edited #Therapeutics #QampA #Jeffrey #Erickson #Vice #President #Business #Development #Triumvira